Article Submission 
        Browse Issue by cover 
         JSRM Article Code 

A Special Issue on 5th Annual Meeting of GSZ.
Click here for more details

Vol. VII Issue: 3 (Special Issue)

Abstracts of the 2nd Meeting of the Asian Cellular Therapy Organization
(PACTO 2011)

2011 Vol. 7 (3): p98-148. doi:10.46582/jsrm.0703016 [HTML] [PDF ]
PMCID: PMC3908267  



(O1) A suitable conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia

Masahiro Imamura (PACTO 2011-O-001)

JSRM Code: 007030700023

(O2) Haploidentica lFamily Donor for Hematopoietic Transplantation to Treat High Risk Hematological Diseases in Adult

Ming Yao, Shang-Ju Wu, Jih-Luh Tang,Yao-Chang Chen (PACTO 2011-O-002)

JSRM Code: 007030700024

(O3) Hematopoietic stem cell transplantation in China

Kaiyan LIU (PACTO 2011-O-003)

JSRM Code: 007030700025


(O4) Depletion of Alloreactive T cells for Tolerance Induction in a Recipient of Kidney and Hematopoietic Stem Cell Transplantations

Kanjana Tangnararatchakit, Wiwat Teerapanich, Usanarat Anurathapan, Wiwat Tapaneeyaolarn, Samart Pakakasama, Saengsuree Jootar, Shimon Slavin, Suradej Hongeng (PACTO 2011-O-004)

JSRM Code: 007030700026

(O5) Current Status of Hematopoietic Stem Cell Transplantation (HSCT) in India

Banavali S(PACTO 2011-O-005)

JSRM Code: 007030700027

(O6) Introduction of WHO-WBMT Vietnam Workshop 2011

Yoshihisa Kodera (PACTO 2011-O-006)

JSRM Code: 007030700028


(O7) Autologous hematopoietic stem cell transplantation in the treatment of severe autoimmune disease

Hiroshi Tsukamoto (PACTO 2011-O-007)

JSRM Code: 007030700029

(O8) The use of Mesenchymal Stromal Cells to modulate Immune Responses: Risk and Benefit

Willem E Fibbe (PACTO 2011-O-008)

JSRM Code: 007030700030

(O9) Nonhomologous Hematopoietic Cell Therapy

Edwin M. Horwitz (PACTO 2011-O-009)

JSRM Code: 007030700031


(O10) New strategy of adoptive-immunotherapy using γ δ T cells

Hirohito Kobayashi(PACTO 2011-O-010)

JSRM Code: 007030700032

(O11) Autologous T cell Therapy Against Tumors

Jaeseung Lim(PACTO 2011-O-011)

JSRM Code: 007030700033

(O12) Ex vivo - expanded allogeneic natural killer cells for clinical application in anti-tumor immunotherapy

Yu-Kyeong Hwang (PACTO 2011-O-012)

JSRM Code: 007030700034


(O13) Dendritic Cell Immunotherapy of Gastrointestinal Tumors

H. Kim Lyerly (PACTO 2011-O-013)

JSRM Code: 007030700035

(O14) Immunotherapy for the Treatment of Advanced Prostate Cancer

Mark W. Frohlich (PACTO 2011-O-014)

JSRM Code: 007030700036

(O15) Clinical translation of Chimeric Antigen Receptor (CAR) messenger RNA (mRNA) loaded T- and NK-cell immunotherapy for safe, tumor-targeted bioactivity

Madhusudan V. Peshwa (PACTO 2011-O-015)

JSRM Code: 007030700037


(O16) Systemic MSC Therapy for Genetic and Acquired Orthopedic Disorders

Satoru Otsuru (PACTO 2011-O-016)

JSRM Code: 007030700038

(O17) Mechanisms of MSC (mesenchymal stem cell) accumulation at the sites of tumors

Ryosuke Uchibori, Keiya Ozawa (PACTO 2011-O-017)

JSRM Code: 007030700039

(O18) Oncolytic measles virus-loaded human bone marrow-derived mesenchymal stem cells as systemic cancer therapeutic agents for human hepatocellular carcinoma

Ong HT, Federspiel MJ, Russell SJ,Peng KW and Hui KM (PACTO 2011-O-018)

JSRM Code: 007030700040


(O19) Phase-I trial of T cell-depleted haplo-identical stem cell transplantation (Haplo-SCT) combined with HSV-TK gene modified T cell add-back

Yuji Heike, Takako Wakeda, Takahiro Fukuda, Shinichiro Mori, IkueiNukaya, Jun-ichiMineno, Kazuto Takesako and Yoich Takaue (PACTO 2011-O-019)

JSRM Code: 007030700041

(O20) Engineered T Cell Immunotherapy for Cancer in Japan

Kazuto Takesako (PACTO 2011-O-020)

JSRM Code: 007030700042

(O21) Adoptive T-Cell Therapy for Cancer from the Benchtop to the Bedside and beyond

Renier J Brentjens (PACTO 2011-O-021)

JSRM Code: 007030700043


(O22) Cartilage Repair -Past, Present and Future

Mitsuo Ochi (PACTO 2011-O-022)

JSRM Code: 007030700044

(O23) Strategies for addressing stand-alone corneal epithelial and endothelial diseases using in vitro expanded cells using Nano scaffolds and polymers

Abraham S (PACTO 2011-O-023)

JSRM Code: 007030700045

(O24) Recent advances in clinical application of human stem cells

Kwang-Hoe Chung, Hyung-Min Chung, Dong Ryul Lee, Jisook Moon, Kwang-Yul Cha (PACTO 2011-O-024)

JSRM Code: 007030700046

(O25) Commercialization of allogeneic, off-the-shelf, adult stem cell drug products using human Umbilical Cord Blood-derived Mesenchymal Stem Cells (hUCBMSCs)

Antonio S J Lee (PACTO 2011-O-025)

JSRM Code: 007030700047

(O26) Generation of Functional Platelets from Pluripotent Stem Cells

Hiromitsu Nakauchi (PACTO 2011-O-026)

JSRM Code: 007030700048


(O27) Transition from standard to cGMP manufacturing in a growing laboratory and transplant service

Lawrence S. Lamb (PACTO 2011-O-027)

JSRM Code: 007030700049

(O28) SANYO’S Approach to Aseptic Cell Manufacturing

Sachihiko Kataoka (PACTO 2011-O-028)

JSRM Code: 007030700050

(O29) Development of Automated cell processing system R-CPX for regenerative medicine

Katsumi Nakashima (PACTO 2011-O-029)

JSRM Code: 007030700051

Clinical development in Asia, from CRO point of view

(O30) 1.The current situation of CRO business in Asia
2.Experience of clinical development/study in Asia.
3.Future of clinical development in Asia from CRO point of view

Hidemi Aida(PACTO 2011-O-030)

JSRM Code: 007030700052


(O31) Stem cell therapy in chronic stroke patients-Phase II trial

Shinn-Zong Lin, Demeral Liu, Woei-Cherng Shyu (PACTO 2011-O-031)

JSRM Code: 007030700053


(O32) Unproven stem cell treatments: Moving targets on the global landscape

Douglas Sipp (PACTO 2011-O-032)

JSRM Code: 007030700054


(O33) NK cell therapy for cancer in practice

Jun-ichi Masuyama (PACTO 2011-O-033)

JSRM Code: 007030700055


(P1) Modified donor lymphocyte infusion in the prophylaxis of relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation for advanced-stage acute leukemia: a retrospective risk factors analysis

Wang-Yu, Liu Dai-Hong, Xu Lan-Ping, Liu Kai-Yan, Chen Huan, Zhang Xiao-Hui, Chen Yu-Hong, Han Wei, Huang Xiao-Jun (PACTO 2011-P-034)

JSRM Code: 007030700056

(P2) Modified donor lymphocyte infusion associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors

Chen-hua Yan, Dai-hong Liu, Lan-ping Xu, Kai-yan Liu, Ting Zhao, Yu Wang, Huan Chen, Yu-hong Chen, Wei Han, Xiao-jun Huang (PACTO 2011-P-035)

JSRM Code: 007030700057

(P3) Lymphoid commitment in human bone marrow CD34-positive cells reflects aging of hematopoietic stem cells.

Yuichi Kodama, Azumi Miyazono, Yasuhiro Okamoto, Yuni Yamaki, Koichiro Kurauchi, Takuro Nishikawa, Takayuki Tanabe, Yuichi Shinkoda, Yoshifumi Kawano (PACTO 2011-P-036)

JSRM Code: 007030700058

(P4) The Study on the Source of Engraftment of Mesenchymal Stem Cells in Patients after Different Source of Hematopoietic Stem Cell Transplantation

Jing Wang, Xiao-Jun Huang, Yu-Hong Chen, Lan-ping Xu, Dai-hong Liu, Huan Chen, Rui-Qin Hou, Xiao-Ying Qin, Kai-yan Liu (PACTO 2011-P-037)

JSRM Code: 007030700059

(P5) Novel natural killer (NK) -cell expansion system for producing large amount (>109 cells) and high purity (>90%) of CD3+ CD56+ cells

Mitsuko Ideno, Mie Yabuuchi, Meiko Jin, Tatsuji Enoki, Naoyuki Sakamoto, Takeshi Ishikawa, Satoshi Kokura, Junichi Mineno (PACTO 2011-P-038)

JSRM Code: 007030700060

(P6) Development of a novel stimulation method to expand CIK cells containing high proportion of CD3+ CD56+ cells

Mitsuko Ideno, Meiko Jin, Tatsuji Enoki, Junichi Mineno (PACTO 2011-P-039)

JSRM Code: 007030700061

(P7) Depletion of CD3-positive cells enables to generate purified and expanded human natural killer cells from peripheral blood mononuclear cells showing strong killer activity

Satoru Saito, Yui Harada, Yoshikazu Yonemitsu (PACTO 2011-P-040)

JSRM Code: 007030700062

(P8) Effect of Herceptin is increased by ex vivo cultured NK cell via antibody-dependent cellular cytotoxicity (ADCC).

Takako Wakeda, Sul Hee Yoon, Yoshinori Ikarashi, Kazunori Aoki, Tsukasa Shinohara, Yuni Yamaki, Yuji Heike (PACTO 2011-P-041)

JSRM Code: 007030700063

(P9) Synergistic anti-cancer effect of large scale simultaneous expanded NK and γ δ T cells with monoclonal antibody drugs

Xuewen Deng, Mie Nieda, Hiroshi Terunuma (PACTO 2011-P-042)

JSRM Code: 007030700064

(P10) Requirements for common chain family cytokines for adoptively transferred γ δ T cell function and homeostasis in vivo

Kazuhiro Kakimi, Takamichi Izumi, Makoto Kondo, Nao Fujieda, Atsushi Kondo, Naohisa Tamura, Ryuji Maekawa, Hirokazu Matsushita (PACTO 2011-P-043)

JSRM Code: 007030700065

(P11) Immune tolerance induction to FVIII in hemophilia A using autologous endothelia progenitors

Hideto Matsui, David Lillicrap, Mitsuhiko Sugimoto, Midori Shima (PACTO 2011-P-044)

JSRM Code: 007030700066

(P12) An Evaluation of CD34+ Cells in the Bone Marrow of various age groups of Indian Population

Abraham S, Manjunath S, Senthilkumar R, Murugan P, Thamaraikannan P, Srinivasan T, Preethy S, Dedeepiya V (PACTO 2011-P-045)

JSRM Code: 007030700067

(P13) Sipuleucel-T: Adaptive Immune Response and Product Characterization from the Phase III IMPACT Trial

Nadeem Sheikh, Daniel Petrylak, Christian Poehlein, James Whitmore, Frances Stewart, Corazon dela Rosa, David Urdal (PACTO 2011-P-046)

JSRM Code: 007030700068

(P14) Cytokine-based log-scale expansion of functional human dendritic cells from PBMC

Yui Harada, Satoru Saito, Yoshikazu Yonemitsu (PACTO 2011-P-047)

JSRM Code: 007030700069

(P15) Efficient antigen presentation by DCs loaded with antigens by electroporation

Koji Nagaoka, Masashi Takahara, Ryuji Maekawa, Takayuki Yoshimoto, Tsuyoshi Teruya, Hiroshi Shiroma (PACTO 2011-P-048)

JSRM Code: 007030700070

(P16) Tissue Factor-triggered Procoagulant Activity of Murine/Human Mesenchymal Stem Cells

Kohei Tatsumi, Kazuo Ohashi, Yoshinori Matsubara, Ayako Kohori, Hiroshi Kakidachi, Akihiro Horii, Takanori Iwata, Teruo Okano (PACTO 2011-P-049)

JSRM Code: 007030700071

(P17) HLA-G Molecules Are Important In Alleviation Of Acute Lung Injury By Placenta Chorion Mesenchymal Stem Cells (pcMSCs) Therapy In Mice Model

Thai-Yen Ling, Meng-Shiue Wu, Yi-Ting Hsieh, Jo-Chi Hsu, Hung-Chih Lai, Fu-Chuo Peng, Jie-Yang Jhuang, Yao-Chang Chen (PACTO 2011-P-050)

JSRM Code: 007030700072

(P18) Useful cell lines (PMDC05/11) of plasmacytoid dendritic cell for cellular immunotherapy

Masuhiro Takahashi, Miwako Narita, Akie Yamahira, Norihiro Watanabe, Shigeo Hashimoto, Yoji Yuki (PACTO 2011-P-051)

JSRM Code: 007030700073

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons 3.0 Unported (CC BY 3.0) Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.